Skip to main content

Acral Melanoma

Melanoma Affecting Volar Skin and Nail Apparatus

  • Living reference work entry
  • First Online:
Melanoma
  • 401 Accesses

Abstract

Acral melanoma is defined as melanoma affecting the palms, soles, and nail apparatus. This is not a synonym of acral lentiginous melanoma in Clark’s classification, which is defined histopathologically. Acral melanoma is characterized by peculiar chromosomal and genetic alterations distinct from other subtypes of melanoma. These characteristics certainly reflect its unique pathogenesis, in which sun exposure is not a major causative factor. In this chapter, genetic characteristics of acral melanoma were first summarized and its molecular pathogenesis was discussed. Amplification of CCND1 and TERT may be early events in the development of acral melanoma. Mutations of BRAF/NRAS may be also involved in the early developmental phase of acral melanoma along with KIT mutations/amplification, which can be utilized as targets by small molecular inhibitors for the treatment of advanced acral melanoma. Next, essential points in the clinical,dermoscopic, and histopathologic diagnoses of acral melanoma were described. Particularly, dermoscopy is very helpful in diagnosing primary lesions of acral melanoma by the parallel ridge pattern, which contrasts with the parallel furrow pattern found in the vast majority of acral nevi. These different pigmentation patterns suggest de novo genesis of acral melanoma, namely, melanoma and nevus arise independently in this anatomical site. Finally, management of acral melanoma is discussed, including some suggestions in the surgical treatment and recently introduced molecular targeting therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Abu-Abed S, Pennell N, Petrella T, Wright F, Seth A, Hanna W (2012) KIT gene mutations and patterns of protein expression in mucosal and acral melanoma. J Cutan Med Surg 16:135–142

    CAS  PubMed  Google Scholar 

  • Ashida A, Takata M, Murata H, Kido K, Saida T (2009) Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas. Int J Cancer 124:862–868

    Article  CAS  PubMed  Google Scholar 

  • Bastian BC (2003) Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 22:3081–3086

    Article  CAS  PubMed  Google Scholar 

  • Bastian BC, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH, Brocker EB, LeBoit PE, Pinkel D (2000) Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 60:1968–1973

    CAS  PubMed  Google Scholar 

  • Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE (2013) Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol 20:3618–3625. https://doi.org/10.1245/s10434-013-3089-0

    Article  PubMed  Google Scholar 

  • Buchbinder EI, Sosman JA, Lawrence DP, McDermott DF, Ramaiya NH, Van den Abbeele AD, Linette GP, Giobbie-Hurder A, Hodi FS (2015) Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma. Cancer 121:4007–4015. https://doi.org/10.1002/cncr.29622

    Article  CAS  PubMed  Google Scholar 

  • Chiu HH, Hu SC, Ke CL, Cheng ST (2008) Dermoscopy identifies histopathologically indiscernible malignant lesion of atypical melanosis of the foot, an early lesion of acral lentiginous melanoma in situ. Dermatol Surg 34:979–983. https://doi.org/10.1111/j.1524-4725.2008.34192.x

    CAS  PubMed  Google Scholar 

  • Choi YD, Chun SM, Jin SA, Lee JB, Yun SJ (2013) Amelanotic acral melanomas: clinicopathological, BRAF mutation, and KIT aberration analyses. J AM Acad Dermatol 69:700–707. https://doi.org/10.1016/j.jaad.2013.06.035

    Article  CAS  PubMed  Google Scholar 

  • Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho HK-H, Aiba S, Bröcker E-B, LeBoit PE, Pinkel D, Bastian BC (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135–2147

    Article  CAS  PubMed  Google Scholar 

  • Curtin JA, Busam K, Pinkel D, Bastian BC (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24:4340–4346

    Article  CAS  PubMed  Google Scholar 

  • Dai B, Cai X, Kong YY, Yang F, Shen XX, Wang LW, Kong JC (2013) Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences. Hum Pathol 44:1472–1478. https://doi.org/10.1016/j.humpath.2013.01.007

    Article  CAS  PubMed  Google Scholar 

  • Diaz A, Puig-Butillé JA, Valera A, Muñoz C, Costa D, Garcia-Herrera A, Carrera C, Sole F, Malvehy J, Puig S, Alos L (2014a) TERT and AURKA gene copy number gains enhance the detection of acral lentiginous melanomas by fluorescence in situ hybridization. J Mol Diagn 16:198–206. https://doi.org/10.1016/j.jmoldx.2013.10.009

    Article  CAS  PubMed  Google Scholar 

  • Diaz A, Puig-Butillé JA, Muñoz C, Costa D, Díez A, Garcia-Herrera A, Carrera C, Badenas C, Solé F, Malvehy J, Puig S, Alos L (2014b) TERT gene amplification is associated with poor outcome in acral lentiginous melanoma. J Am Acad Dermatol 71:839–841. https://doi.org/10.1016/j.jaad.2014.05.035

    Article  PubMed  Google Scholar 

  • Furney SJ, Turajlic S, Fenwick K, Lambros MB, MacKay A, Ricken G, Mitsopoulos C, Kozarewa I, Hakas J, Zvelebil M, Lord CJ, Ashworth A, Reis-Filho JS, Herlyn M, Murata H, Marais R (2012) Genomic characterisation of acral melanoma cell lines. Pigment Cell Melanoma Res 25:488–492. https://doi.org/10.1111/j.1755-148X.2012.01016.x

    Article  CAS  PubMed  Google Scholar 

  • Guo J, Si L, Kong Y, Flaherty KT, Xu X, Zhu Y, Corless CL, Li L, Li H, Sheng X, Cui C, Chi Z, Li S, Han M, Mao L, Lin X, Du N, Zhang X, Li J, Wang B, Qin S (2011) Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-KIT mutation or amplification. J Clin Oncol 29:2904–2909

    Article  CAS  PubMed  Google Scholar 

  • Haigh PI, DiFronzo LA, McCready DR (2003) Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Can J Surg 46:419–426

    PubMed  PubMed Central  Google Scholar 

  • Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, Patch AM, Kakavand H, Alexandrov LB, Burke H, Jakrot V, Kazakoff S, Holmes O, Leonard C, Sabarinathan R, Mularoni L, Wood S, Xu Q, Waddel N, Tembe V, Pupo GM, De Paoli-Iseppi R, Vilain RE, Shang P, Lau LMS, Dagg RA, Schramm SJ, Pritchard A, Dutton-Regester K, Newell F, Fitzgerald A, Shang CA, Grimmond SM, Pickett HA, Yang JY, Stretch JR, Behren A, Kefford RF, Hersey P, Long GV, Cebon J, Shackleton M, Spillane AJ, Saw RPM, Lopez-Bigas N, Pearson JV, Thompson JF, Scolyer RA, Mann GJ (2017) Whole-genome landscapes of major melanoma subtypes. Nature 545(7653):175–180. https://doi.org/10.1038/nature22071

    Article  CAS  PubMed  Google Scholar 

  • Hodi FS, Corless CL, Giobbie-Hurder A, Fletcher JA, Zhu M, Marino-Enriquez A, Friedlander P, Gonzalez R, Weber JS, Gajewski TF, O’Day SJ, Kim KB, Lawrence D, Flaherty KT, Luke JJ, Collichio FA, Ernstoff MS, Heinrich MC, Beadling C, Zukotynski KA, Yap JT, Van den Abbeele AD, Demetri GD, Fisher DE (2013) Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol 31:3182–3190. https://doi.org/10.1200/JCO.2012.47.7836

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johnson DB, Peng C, Abramson RG, Ye F, Zhao S, Wolchok JD, Sosman JA, Carvajal RD, Ariyan CE (2015) Clinical activity of ipilimumab in acral melanoma: a retrospective review. Oncologist 20:648–652. https://doi.org/10.1634/theoncologist.2014-0468

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jung HJ, Kweon SS, Lee JB, Lee SC, Yun SJ (2013) A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress. JAMA Dermatol 149:1281–1288. https://doi.org/10.1001/jamadermatol.2013.5853

    Article  PubMed  Google Scholar 

  • Kilinc Karaarslan I, Akalin T, Unal I, Ozdemir F (2007) Atypical melanosis of the foot showing a dermoscopic feature of the parallel ridge pattern. J Dermatol 34:56–59

    Article  PubMed  Google Scholar 

  • Koga H, Saida T (2011) Revised 3-step dermoscopic algorithm for the management of acral melanocytic lesions. Arch Dermatol 147:741–743

    Article  PubMed  Google Scholar 

  • Koga H, Saida T, Uhara H (2011) Key point in dermoscopic differentiation between early nail apparatus melanoma and benign longitudinal melanonychia. J Dermatol 38:45–52

    Article  PubMed  Google Scholar 

  • Koga H, Yoshikawa S, Sekiguchi A, Fujii J, Saida T, Sota T (2014) Automated evaluation system of dermoscopic images of longitudinal melanonychia: proposition of a discrimination index for detecting early nail apparatus melanoma. J Dermatol 41:867–871

    Article  PubMed  Google Scholar 

  • Lallas A, Kyrgidis A, Koga H, Moscarella E, Tschandl P, Apalla Z, Di Stefani A, Ioannides D, Kittler H, Kobayashi K, Lazaridou E, Longo C, Phan A, Saida T, Tanaka M, Thomas L, Zalaudek I, Argenziano G (2015) The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma. Br J Dermatol 173:1041–1049. https://doi.org/10.1111/bjd.14045

    Article  CAS  PubMed  Google Scholar 

  • Liau JY, Tsai JH, Jeng YM, Chu CY, Kuo KT, Liang CW (2014) TERT promoter mutation is uncommon in acral lentiginous melanoma. J Cutan Pathol 41:504–508. https://doi.org/10.1111/cup.12323

    Article  PubMed  Google Scholar 

  • Murata H, Ashida A, Takata M, Yamaura M, Bastian BC, Saida T (2007) Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas. Cancer Sci 98:958–963

    Article  CAS  PubMed  Google Scholar 

  • Namiki T, Tanemura A, Valencia JC, Coelho SG, Passeron T, Kawaguchi M, Vieira WD, Ishikawa M, Nishijima W, Izumo T, Kaneko Y, Katayama I, Yamaguchi Y, Yin L, Polley EC, Liu H, Kawakami Y, Eishi Y, Takahashi E, Yokozeki H, Hearing VJ (2011) AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma. Proc Natl Acad Sci U S A 108:6597–6602. https://doi.org/10.1073/pnas.1007694108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nogita T, Wong TY, Ohara K, Mizushima J, Mihm MC Jr, Kawashima M (1994) Atypical melanosis of the foot: a report of three cases in Japanese populations. Arch Dermatol 130:1042–1045

    Article  CAS  PubMed  Google Scholar 

  • North JP, Kageshita T, Pinkel D, LeBoit PE, Bastian BC (2008) Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. J Invest Dermatol 128:2024–2030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Okamoto N, Aoto T, Uhara H, Yamazaki S, Akutsu H, Umezawa A, Nakauchi H, Miyachi Y, Saida T, Nishimura EK (2014) A melanocytemelanoma precursor niche in sweat glands of volar skin. Pigment Cell Melanoma Res 27:1039–1050

    Article  CAS  PubMed  Google Scholar 

  • Phan A, Dalle S, Touzet S, Ronger-Savlé S, Balme B, Thomas L (2010) Dermoscopic features of acral lentiginous melanoma in a large series of 110 cases in a white population. Br J Dermatol 162:765–771

    Article  CAS  PubMed  Google Scholar 

  • Puig-Butillé JA, Badenas C, Ogbah Z, Carrera C, Aguilera P, Malvehy J, Puig S (2013) Genetic alterations in RAS regulated pathway in acral lentiginous melanoma. Exp Dermatol 22:148–150. https://doi.org/10.1111/exd.12080

    Article  PubMed  PubMed Central  Google Scholar 

  • Reed R (1976) Acral lentiginous melanoma. In: Hartmann W, Reed R (eds) New concepts in surgical pathology of the skin. Wiley, New York, pp 89–90

    Google Scholar 

  • Ronger S, Touzet S, Ligeron C, Balme B, Viallard AM, Barrut D, Colin C, Thomas L (2002) Dermoscopic examination of nail pigmentation. Arch Dermatol 138:1327–1333

    Article  PubMed  Google Scholar 

  • Saida T (1989) Malignant melanoma in situ on the sole of the foot: its clinical and histopathologic characteristics. Am J Dermatopathol 11:124–130

    Article  CAS  PubMed  Google Scholar 

  • Saida T (1992) Heterogeneity of the site of origin of malignant melanoma in ungual areas: “subungual” malignant melanoma may be a misnomer. Br J Dermatol 126:529

    CAS  PubMed  Google Scholar 

  • Saida T (2007) Morphological and molecular uniqueness of acral melanoma. Expert Rev Dermatol 2:125–131

    Article  CAS  Google Scholar 

  • Saida T, Koga H (2007) Dermoscopic patterns of acral melanocytic nevi: their variations, changes, and significance. Arch Dermatol 143:1423–1426

    PubMed  Google Scholar 

  • Saida T, Koga H (2013) Dermoscopy of pigmented lesions of the palms and soles. In: UpToDate, Tsao H (ed), UpToDate, Waltham

    Google Scholar 

  • Saida T, Oshima Y (1989) Clinical and histopathologic characteristics of early lesions of subungual malignant melanoma. Cancer 63:556–560

    Article  CAS  PubMed  Google Scholar 

  • Saida T, Miyazaki A, Oguchi S, Ishihara Y, Yamazaki Y, Murase S, Yoshikawa S, Tsuchida T, Kawabata Y, Tamaki K (2004) Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multi-center study in Japan. Arch Dermatol 140:1233–1238

    Article  PubMed  Google Scholar 

  • Saida T et al (2007) Acral melanoma. In: Soyer HP, Argenziano G, Hofmann-Wellenhof R, Johr RH (eds) Color atlas of melanocytic lesions of the skin. Springer, Berlin, pp 196–203

    Google Scholar 

  • Saida T, Koga H, Uhara H (2011a) Key points in dermoscopic differentiation between early acral melanoma and acral nevus. J Dermatol 38:25–34. https://doi.org/10.1111/j.1346-8138.2010.01174.x

    Article  PubMed  Google Scholar 

  • Saida T, Koga H, Goto Y, Uhara H (2011b) Characteristic distribution of melanin columns in the cornified layer of acquired acral nevus: an important clue for histopathologic differentiation from early acral melanoma. Am J Dermatopathol 33:468–473

    Article  PubMed  Google Scholar 

  • Sakaizawa K, Ashida A, Uchiyama A, Ito T, Fujisawa Y, Ogata D, Matsushita S, Fujii K, Fukushima S, Shibayama Y, Hatta N, Takenouchi T, Uehara J, Okuyama R, Yamazaki N, Uhara H (2015) Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients. J Dermatol Sci 80:33–37. https://doi.org/10.1016/j.jdermsci.2015.07.012

    Article  CAS  PubMed  Google Scholar 

  • Sauter ER, Yeo UC, von Stemm A, Zhu W, Litwin S, Tichansky DS, Pistritto G, Nesbit M, Pinkel D, Herlyn M, Bastian BC (2002) Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res 62:3200–3206

    CAS  PubMed  Google Scholar 

  • Seiji M, Takahashi M (1974) Malignant melanoma with adjacent intraepidermal proliferation. Tohoku J Exp Med 114:93–107

    Article  CAS  PubMed  Google Scholar 

  • Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, Dummer R, North J, Pincus L, Ruben B, Rickaby W, D’Arrigo C, Robson A, Bastian BC (2015) The genetic evolution of melanoma from precursor lesions. N Engl J Med 373:1926–1936. https://doi.org/10.1056/NEJMoa1502583

    Article  PubMed  Google Scholar 

  • Stevens NG, Liff JM, Weiss NS (1990) Plantar melanoma: is the incidence of melanoma of the sole of foot really higher in blacks than whites? Int J Cancer 45:691–693

    Article  CAS  PubMed  Google Scholar 

  • Sureda N, Phan A, Poulalhon N, Balme B, Dalle S, Thomas L (2011) Conservative surgical management of subungual (matrix derived) melanoma: report of seven cases and literature review. Br J Dermatol 165:852–858. https://doi.org/10.1111/j.1365-2133.2011.10477.x

    Article  CAS  PubMed  Google Scholar 

  • The Cancer Genome Network (2015) Genomic classification of cutaneous melanoma. Cell 161:1681–1696. https://doi.org/10.1016/j.cell.2015.05.044

    Article  Google Scholar 

  • Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D (2009) Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 22:1446–1456. https://doi.org/10.1038/modpathol.2009.116

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Turajlic S, Furney SJ, Lambros MB, Mitsopoulos C, Kozarewa I, Geyer FC, Mackay A, Hakas J, Zvelebil M, Lord CJ, Ashworth A, Thomas M, Stamp G, Larkin J, Reis-Filho JS, Marais R (2012) Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res 22:196–207. https://doi.org/10.1101/gr.125591.111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Uhara H, Koga H, Takata M, Saida T (2009) The whiteboard marker as a useful tool for the dermoscopic “furrow ink test”. Arch Dermatol 145:1331–1332

    Article  PubMed  Google Scholar 

  • Yamazaki N, Tanaka R, Tsutsumida A, Namikawa K, Eguchi H, Omata W, Oashi K, Ogawa T, Hayashi A, Nakamura N, Tsuta K (2015) BRAF V600 mutations and pathological features in Japanese melanoma patients. Melanoma Res 25:9–14. https://doi.org/10.1097/CMR

    Article  CAS  PubMed  Google Scholar 

  • Zebary A, Omholt K, Vassilaki I, Höiom V, Lindén D, Viberg L, Kanter-Lewensohn L, Johansson CH, Hansson J (2013) KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma. J Dermatol Sci 72:284–289. https://doi.org/10.1016/j.jdermsci.2013.07.013

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toshiaki Saida .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media LLC

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Saida, T. (2018). Acral Melanoma. In: Fisher, D., Bastian, B. (eds) Melanoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7322-0_5-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7322-0_5-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7322-0

  • Online ISBN: 978-1-4614-7322-0

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics